FOXC1: an emerging marker and therapeutic target for cancer

被引:0
|
作者
B Han
N Bhowmick
Y Qu
S Chung
A E Giuliano
X Cui
机构
[1] Samuel Oschin Comprehensive Cancer Institute,Department of Surgery
[2] Cedars-Sinai Medical Center,Department of Medicine
[3] Samuel Oschin Comprehensive Cancer Institute,undefined
[4] Cedars-Sinai Medical Center,undefined
来源
Oncogene | 2017年 / 36卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The Forkhead box C1 (FOXC1) transcription factor is involved in normal embryonic development and regulates the development and function of many organs. Most recently, a large body of literature has shown that FOXC1 plays a critical role in tumor development and metastasis. Clinical studies have demonstrated that elevated FOXC1 expression is associated with poor prognosis in many cancer subtypes, such as basal-like breast cancer (BLBC). FOXC1 is highly and specifically expressed in BLBC as opposed to other breast cancer subtypes. Its functions in breast cancer have been extensively explored. This review will summarize current knowledge on the function and regulation of FOXC1 in tumor development and progression with a focus on BLBC, as well as the implications of these new findings in cancer diagnosis and treatment.
引用
收藏
页码:3957 / 3963
页数:6
相关论文
共 50 条
  • [31] FOXC1 interacts with components of the nucleo/cytoskeleton
    Berry, FB
    Mirzayans, F
    Coca-Prados, M
    Walter, MA
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 : U83 - U83
  • [32] FOXC1 Mediates the Basal Phenotype in BRCA1-mutant Breast Cancer
    Johnson, J.
    Choi, M.
    Han, B.
    Qu, Y.
    Dadmanesh, F.
    Zhang, X.
    Karlan, B.
    Giuliano, A. E.
    Cui, X.
    Amersi, F.
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 : S57 - S57
  • [33] Regulation of FOXC1 levels by post-translational modifications: Implications for glaucoma pathologies through alterations in FOXC1 stability
    Berry, FB
    Mirzayans, F
    Walter, MA
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46
  • [34] FOXC1: A Specific Biomarker for Triple Negative Breast Cancer Diagnosis and Classification
    Li, Ming
    Lv, Hong
    Zhong, Siyuan
    Zhou, Shuling
    Li, Anqi
    Lu, Hongfen
    Yang, Wentao
    MODERN PATHOLOGY, 2021, 34 (SUPPL 2) : 122 - 123
  • [35] The clinicopathologic significance of FOXC1 in BRCA-mutant breast cancer.
    Choi, Michael Phillip
    Cui, Xiaojiang
    Dadmanesh, Farnaz
    Liles, Georgia
    Zhang, Xiao
    Karlan, Beth
    Glullano, Armando E.
    Amersi, Farin F.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [36] FOXC1: A Specific Biomarker for Triple Negative Breast Cancer Diagnosis and Classification
    Li, Ming
    Lv, Hong
    Zhong, Siyuan
    Zhou, Shuling
    Li, Anqi
    Lu, Hongfen
    Yang, Wentao
    LABORATORY INVESTIGATION, 2021, 101 (SUPPL 1) : 122 - 123
  • [37] The exploratory analysis of dysregulated transcription factor FOXC1 in pan-cancer
    Brown, Alanna
    Wu, Zexun
    Cao, Huan
    Falzarano, Sara M.
    Buxbaum, Sarah G.
    Rhie, Suhn K.
    CANCER RESEARCH, 2023, 83 (07)
  • [38] Contribution of FOXC1 to the progression and metastasis and prognosis of human colon cancer.
    Li, Dawei
    Li, Qingguo
    Zhuo, Changhua
    Xu, Ye
    Cai, Sanjun
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [39] Progress with FOXC1 gene dosage.
    Lehmann, OJ
    Jordan, TL
    Ebenezer, N
    Ocaka, L
    Hitchings, RA
    Khaw, PT
    Walter, MA
    Povey, S
    Sowden, J
    Bhattacharya, SS
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2001, 42 (04) : S530 - S530
  • [40] Impact of OGT deregulation on EZH2 target genes FOXA1 and FOXC1 expression in breast cancer cells
    Forma, Ewa
    Jozwiak, Pawel
    Ciesielski, Piotr
    Zaczek, Agnieszka
    Starska, Katarzyna
    Brys, Magdalena
    Krzeslak, Anna
    PLOS ONE, 2018, 13 (06):